Literature DB >> 9565186

Confirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience.

S B Roberts1, C A Hill, B Dean, N A Keks, K Opeskin, D L Copolov.   

Abstract

OBJECTIVE: This study examines the reliability of antemortem diagnoses of schizophrenia using DSM-IV criteria.
METHOD: The case histories of 83 subjects with a provisional diagnosis of schizophrenia at autopsy were retrospectively reviewed using a semi-structured chart review and application of DSM-IV criteria. Agreement between antemortem and postmortem diagnoses of schizophrenia was examined, as well as the concordance between DSM-IV diagnoses and previously obtained diagnoses using DSM-III-R and ICD-10 criteria for schizophrenia.
RESULTS: According to DSM-IV, 30.1% of cases did not have schizophrenia, compared to 36.1% using DSM-III-R criteria and 51.8% of cases using ICD-10 criteria. Concordance between DSM-IV and DSM-III-R diagnoses of schizophrenia was excellent (kappa = 0.81), but only fair between DSM-IV and ICD-10 (kappa = 0.57). Of the cases that did not meet the formal criteria for schizophrenia, the majority were reassigned diagnoses of schizoaffective disorder and affective disorder.
CONCLUSIONS: The use of human brain tissue in postmortem studies of schizophrenia must be linked to standardised diagnostic assessment procedures. Diagnoses can be upgraded with the development of new criteria, providing sufficient clinical data is available in case histories.

Entities:  

Mesh:

Year:  1998        PMID: 9565186     DOI: 10.3109/00048679809062709

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  25 in total

1.  Postmortem diagnosis and toxicological validation of illicit substance use.

Authors:  Elin Lehrmann; Zoan R Afanador; Amy Deep-Soboslay; Gloria Gallegos; William D Darwin; Ross H Lowe; Allan J Barnes; Marilyn A Huestis; Jean L Cadet; Mary M Herman; Thomas M Hyde; Joel E Kleinman; William J Freed
Journal:  Addict Biol       Date:  2008-01-14       Impact factor: 4.280

2.  Catechol-O-methyltransferase (COMT) genotypes are associated with varying soluble, but not membrane-bound COMT protein in the human prefrontal cortex.

Authors:  Georgia M Parkin; Madhara Udawela; Andrew Gibbons; Elizabeth Scarr; Brian Dean
Journal:  J Hum Genet       Date:  2018-09-14       Impact factor: 3.172

3.  Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.

Authors:  Elizabeth Scarr; Shaun Hopper; Valentina Vos; Myoung Suk Seo; Ian Paul Everall; Timothy Douglas Aumann; Gursharan Chana; Brian Dean
Journal:  J Psychiatry Neurosci       Date:  2018-08       Impact factor: 6.186

4.  Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.

Authors:  Ikwunga Wonodi; O Colin Stine; Korrapati V Sathyasaikumar; Rosalinda C Roberts; Braxton D Mitchell; L Elliot Hong; Yasushi Kajii; Gunvant K Thaker; Robert Schwarcz
Journal:  Arch Gen Psychiatry       Date:  2011-07

5.  The association between formal thought disorder and finger print asymmetry in children with a psychiatric disorder: an exploratory study.

Authors:  Esther I de Bruin; Pieter F A de Nijs; Frank C Verhulst; Anja C Huizink
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-07-18       Impact factor: 4.785

6.  AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder.

Authors:  Andrew Stuart Gibbons; Lucy Brooks; Elizabeth Scarr; Brian Dean
Journal:  J Affect Disord       Date:  2011-10-28       Impact factor: 4.839

7.  Is schizophrenia a neurodegenerative disease? Evidence from age-related decline of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched nonpsychiatric controls.

Authors:  Jagadeesh Rao; Joshua Chiappelli; Peter Kochunov; William T Regenold; Stanley I Rapoport; L Elliot Hong
Journal:  Neurodegener Dis       Date:  2014-12-17       Impact factor: 2.977

Review 8.  Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?

Authors:  Lennart B Jansson; Josef Parnas
Journal:  Schizophr Bull       Date:  2006-12-08       Impact factor: 9.306

9.  Associations between catechol-O-methyltransferase (COMT) genotypes at rs4818 and rs4680 and gene expression in human dorsolateral prefrontal cortex.

Authors:  Brian Dean; Georgia M Parkin; Andrew S Gibbons
Journal:  Exp Brain Res       Date:  2020-01-20       Impact factor: 1.972

10.  Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia.

Authors:  Ikwunga Wonodi; L Elliot Hong; O Colin Stine; Braxton D Mitchell; Amie Elliott; Rosalinda C Roberts; Robert R Conley; Robert P McMahon; Gunvant K Thaker
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-03-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.